肿瘤坏死因子相关凋亡诱导配体在甲状腺癌治疗中的应用
摘要
肿瘤坏死因子相关凋亡诱导配体(tumor necrosis factorrelated apoptosis inducing ligand,TRAIL)又称凋亡素2配体(Apo-2L),属于肿瘤坏死因子(TNF)家族一种II型跨膜蛋白。其最显著的生物学特点是具有选择性的细胞毒性作用,
出处
《中华内分泌外科杂志》
CAS
2012年第4期265-267,共3页
Chinese Journal of Endocrine Surgery
基金
基金项目:吉林省科技厅资助课题(20110136)
参考文献26
-
1Mitsiades N, Poulaki V, Balafouta ST, et al. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-relate apoptosis-inducing ligand [ J ]. Cancer Res, 2000,60( 15 ) :4122-4129.
-
2Park JW, Wong MG, Lobo M, et al. Modulation of tumor necrosis factor---related apoptosis-inducing ligand-induced apoptosis chemo- therapy in thyroid cancer cell lines [ J ]. Thyroid, 2003,13 ( 12 ) : 1103-1110.
-
3Maldonado ME, Bousserouel S, Goss F, et al. Implication of NF- KB and p53 in the expression of TRAIL-death receptors and apop- tosis by apple procyanidins in human metastatic SW620 cells [ J ]. Biomedica,2010,30 (4) :577-586.
-
4De Toni EN, Thieme SE, Herbst A, et al. OPG is regulated by be- ta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer[ J]. Clin Cancer Res,2008,14( 15 ) :4713-4718.
-
5Pacifico F, Crescenzi E, Mellone S, et al. Nuclear factor- kappa I B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a [ J ]. J Clin Endocrinol Metab, 2010, 95 ( 3 ) : 1421-1430.
-
6Lannetti A, Pacifico F, Aequaviva R, et al. The neutrophil gelati- nase-associated lipocalin( NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells [ J ]. Proe Natl Acad Sci USA ,2008,105 ( 37 ) : 14058-14063.
-
7Bauerle KT, Schweppe RE, Hauqen BR, et al. Inhibition of nucle- ar factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion[ J]. Mol Cancer,2010,9 : 117.
-
8Aydin C, Sanlioglu AD, Bisgin A, et al. NF-KB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL [ J]. BMC Cancer,2010,10:584.
-
9Liu F, Hu X, Zimmerman M, et al. TNFa cooperates with IFN- to repress Bcl-xL expresstion to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis[ J]. PLoS One,2011,6(1) :e16241.
-
10Meng Z, Mitsutake N, Nakashima M, et al. Dehydroxymethylep- oxyquinomicin, a novel nuclear factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastie thyroid cancer cells [ J ]. Endocrinology,2008,149 ( 11 ) :5357-5365.
二级参考文献22
-
1张海燕,高大新,刘国良.Survivin基因及其与肿瘤靶向治疗[J].肿瘤防治杂志,2005,12(10):787-790. 被引量:13
-
2张海燕,高大新,温滨红,刘国良.存活素与血管内皮生长因子在甲状腺癌中的表达及其意义[J].中华内分泌代谢杂志,2005,21(3):244-247. 被引量:11
-
3Pan G, Ni J, Wei Y F, et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL [J]. Science, 1997, 277(5327) :815-818.
-
4Shiraishi T, Yoshida T, Nakata S, et al. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells[J]. Cancer Res, 2005, 65(14) :6364-6370.
-
5LeBlanc H N, Ashkenazi A. Apo2L/TRAIL and its death and decoyreceptors[J]. Cell Death Differ, 2003, 10(1): 66-75.
-
6Mitsiades N, Poulaki V, Tseleni-Balafouta S, et al. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand [J]. Cancer Res, 2000, 60(15):4122-4129.
-
7Wang S H, Mezosi E, Wolf J M, et al. IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma ceils by upregulating Bak expression[J]. Oncogene, 2004, 23(4): 928-935.
-
8Du Zhen-Xian, Wang Hua-Qin, ZhangHai-Yan, et al. Involvement of glyceraldehyde-3 phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells [J]. Endocrinology,2007,148(9) :4352 -4361.
-
9Fulda S, Debatin K M. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the che mopreventive agent resveratrol[J]. Cancer Res, 2004, 64 (1) : 337- 346.
-
10Griffith T S, Fialkov J M, Scott D L, et al. Induction and regu- lation of tumor necrosis factor-related apoptosis-inducing ligand/ Apo-2 ligan&mediated apoptosis in renal cell carcinoma [J]. Cancer Res, 2002,62(11) : 3093-3099.
共引文献14
-
1张海燕,都镇先,尹福在,高大新,杨向红,刘国良.存活素与血管内皮生长因子反义寡核苷酸对人甲状腺髓样癌裸鼠模型的作用[J].中华内分泌代谢杂志,2006,22(2):139-143. 被引量:1
-
2都镇先,张海燕,尹福在,杨向红,刘国良.血管内皮生长因子反义寡核苷酸在人甲状腺髓样癌裸鼠模型中的抑瘤作用[J].中华肿瘤防治杂志,2006,13(19):1452-1456. 被引量:4
-
3王化修,伍石华,蒙松年,肖小芹,杨华,张灿云.存活素和CD44 V6在甲状腺癌组织中的表达及意义[J].实用癌症杂志,2006,21(6):588-590. 被引量:8
-
4都镇先,张海燕,尹福在,杨向红,刘国良.存活素反义寡核苷酸在人甲状腺髓样癌裸鼠模型中的抑瘤作用[J].中国组织化学与细胞化学杂志,2007,16(1):40-44. 被引量:2
-
5高娜,张育.凋亡调节蛋白Survivin与类风湿关节炎[J].中华风湿病学杂志,2007,11(11):690-693. 被引量:2
-
6覃丹露,罗佐杰.VEGF、TSP-1与内分泌肿瘤血管生成的研究进展[J].医学综述,2007,13(19):1446-1448. 被引量:4
-
7陈利民,郑建华,王烯冬.P53、survivin的研究进展[J].疾病监测与控制,2009,3(4):243-245. 被引量:6
-
8都镇先,张海燕,邓娓娓,王华芹.衣霉素联合TRAIL促甲状腺癌细胞凋亡机制的研究[J].中华肿瘤防治杂志,2009,16(14):1041-1044. 被引量:5
-
9寇军燕,张沂平.TRAIL的抗肿瘤机制及其应用[J].中华肿瘤防治杂志,2010,17(22):1892-1895. 被引量:2
-
10张晓春,拓炜,陈诚.衣霉素与TRAIL协同诱导11q23异常急性淋巴细胞白血病细胞株凋亡的体外研究[J].宁夏医科大学学报,2011,33(9):815-818. 被引量:1
-
1柯杨.细胞周期——开辟癌治疗新途径[J].中国高校技术市场,2001(11):34-35. 被引量:1
-
2张树英,易成.TRAIL在肿瘤治疗中的新策略[J].华西医学,2008,23(3):665-666.
-
3张霄翔,纪文婷,张庆林.肿瘤坏死因子相关的凋亡诱导配体与肿瘤治疗[J].安徽医药,2008,12(2):97-99. 被引量:2
-
4高显峰,王广义,吕国悦,谢淑丽.胰腺癌细胞对TRAIL耐药机制的研究进展[J].吉林医学,2010,31(5):665-666. 被引量:1
-
5吴秀贤,笕善行.抗DR4和抗DR5单抗在肿瘤治疗中的研究进展[J].中华外科杂志,2009,47(2):146-148.
-
6陈朝飞,房静远.丝裂原激活蛋白激酶信号转导途径与胃癌[J].中华消化杂志,2005,25(5):316-318. 被引量:1
-
7张良鹏,吴小娟,汤绍辉.RNA干扰与肝细胞癌治疗[J].广东医学,2012,33(6):870-872. 被引量:2
-
8王梁华,焦炳华.肿瘤坏死因子家族新成员——TRAIL[J].生物化学与生物物理进展,1998,25(5):392-395. 被引量:11
-
9刘佳雯,杨玉强,张治国.激光光动力学治疗癌症的新进展[J].哈尔滨工业大学学报,2006,38(3):362-366. 被引量:2
-
10谢康康,王德杰,吴伟.uPA、uPAR在甲状腺癌中的表达及意义[J].浙江实用医学,2015,20(5):338-339.